Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vaping prevention program put to the test in middle schools

NCT ID NCT04843501

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program called CATCH My Breath to see if it could delay or prevent e-cigarette use in middle school students. About 1,400 students from 20 schools took part, with half getting the program and half receiving standard health lessons. Researchers tracked how many students started using e-cigarettes over three years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,059 people

The number who actually took part.

Started

Dec 2020

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 15 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

School Inclusion Criteria: * enrollment of at least 70 students in each of the 6th, 7th, and 8th grades * school location is 100 miles of research site School Exclusion Criteria: * schools that have participated in the previous 2 pilot tests * currently implementing CMB Student Inclusion Criteria: * enrollment in the 6th grade at a study school * willingness to complete the measurements six times during the study Student Exclusion Criteria: \- severe disabilities that limit their participation Parent Inclusion Criteria: * ability to communicate in English or Spanish * caretaker of a 6th-grade child. Parent Exclusion Criteria: -inability to communicate in English or Spanish

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for E-cigarette use are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Vaping

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University of Texas Health Science Center at Houston School of Public Health at Austin

    Austin, Texas, 78701, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.